Investor Group Named Lead Plaintiff In Securities Suit, May Aggregate Losses
BOSTON — A group of investors may aggregate their losses and has met all statutory requirements to serve as lead plaintiff in a securities class action lawsuit against a biopharmaceutical company...To view the full article, register now.
Already a subscriber? Click here to view full article